International Stroke Conference 2025  /  Risk Factors and Prevention Posters I  /  Elevated Trimethylamine N-Oxide Levels Are Associated with Ischemic Stroke and Hypertensive Intracerebral Hemorrhage
Logo

American Heart Association

  228
  0

Final ID: WP336

Elevated Trimethylamine N-Oxide Levels Are Associated with Ischemic Stroke and Hypertensive Intracerebral Hemorrhage

Abstract Body: Background
Trimethylamine N-oxide (TMAO), a gut microbiome-derived metabolite trimethylamine-containing nutrients, is mechanistically linked to atherosclerosis progression and platelet aggregation, leading to cardiovascular disease. Recent studies have showed that TMAO levels are elevated in patients with ischemic stroke; however, its association with heterogenous pathophysiology of stroke remains unknown. In this study, we aimed to investigate what stroke subtypes plasma TMAO levels were associated with.
Methods
The study was prospectively conducted at a single center in Japan between 2021 and 2022, enrolling acute stroke patients and non-stroke subjects. Blood samples were collected at the first post-hospitalization or during a medical checkup after obtaining written informed consent. Plasma TMAO levels were measured using liquid chromatography-mass spectrometry. We compared TMAO levels between acute stroke patients and non-stroke subjects, as well as among stroke subtypes.
Results
We enrolled 162 stroke patients (median age, 74) and 50 non-stroke subjects (75). Plasma TMAO levels were significantly higher in stroke patients than in non-stroke subjects (median [Interquartile range]: 3.0 [1.1–7.7] vs. 2.1 [0.8–4.2] µM, p = 0.01), and high TMAO levels (TMAO > 5.0 µM) distinguished stroke patients from non-stroke subjects (odds ratio 1.20, 95%CI 1.06-1.36, p < 0.01). High TMAO levels were independently associated with stroke after adjusted for age, sex, and conventional vascular risk factors (adjusted odds ratio 1.14, 95% confidence interval [CI] 1.01–1.28, p < 0.05). The proportion of patients with elevated TMAO levels was significantly higher in patients with cardioembolic stroke (11/34 [32%]), large-artery atherosclerosis (11/28 [39%]), small-vessel occlusion (11/36 [31%]), and hypertensive intracerebral hemorrhage (15/43 [35%]) than in non-stroke subjects (7/50 [14%]) (p < 0.05), but did not differ between patients with cerebral amyloid angiopathy (CAA)-related intracerebral hemorrhage (1/9 [11%]) and non-stroke subjects (p = 0.9).
Conclusions
High plasma TMAO levels were significantly associated with hypertensive intracerebral hemorrhage as well as with each ischemic stroke type, but not with CAA-related intracerebral hemorrhage, suggesting that TMAO may confer a risk for stroke via the development of atherosclerosis.
  • Nukata, Ryotaro  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Tonomura, Shuichi  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Yamamoto, Akimasa  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Iwamoto, Soya  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Chiba, Tetsuya  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Nakaoka, Yoshikazu  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Hattori, Yorito  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
  • Ihara, Masafumi  ( National Cerebral and Cardiovascular Center , Osaka , Japan )
    • Author Disclosures:
    Ryotaro Nukata: DO NOT have relevant financial relationships | shuichi tonomura: DO NOT have relevant financial relationships | Akimasa Yamamoto: DO NOT have relevant financial relationships | Soya Iwamoto: No Answer | Tetsuya Chiba: No Answer | Yoshikazu Nakaoka: DO have relevant financial relationships ; Consultant:Abbvie:Active (exists now) ; Speaker:Chugai:Expected (by end of conference) ; Research Funding (PI or named investigator):Janssen:Active (exists now) ; Research Funding (PI or named investigator):Kaneka:Active (exists now) ; Research Funding (PI or named investigator):JSR:Active (exists now) ; Research Funding (PI or named investigator):JT:Past (completed) ; Consultant:Janssen:Past (completed) ; Consultant:Chugai:Past (completed) | Yorito Hattori: DO NOT have relevant financial relationships | Masafumi Ihara: DO NOT have relevant financial relationships
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Risk Factors and Prevention Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
A Pro-Inflammatory Diet Potentiates Genetic Risk for Coronary Artery Disease: A Longitudinal Analysis of the Framingham Offspring Study

Mansoor Masab, Ibrahim Andrew, Hamide Ali, Rizwan Affan, Babar Maryam, Arain Aymen

A Culturally Competent Journey in Nutrition Education

Banks Shelby, Barcelona Jeanne

More abstracts from these authors:
Association between oral carriage of Streptococcus mutans positive for collagen-binding protein Cnm and stroke onset age: A subanalysis of RAMESSES study

Yamamoto Akimasa, Ihara Masafumi, Hattori Yorito, Abe Soichiro, Hosoki Satoshi, Nakazawa Shinsaku, Tonomura Shuichi, Saito Satoshi, Takegami Misa, Nakano Kazuhiko

Streptococcus anginosus Enrichment in the Gut is a Feature of Stroke and a Predictor of Poor Prognosis

Tonomura Shuichi, Hattori Yorito, Yamamoto Akimasa, Iwamoto Soya, Nukata Ryotaro, Chiba Tetsuya, Nakaoka Yoshikazu, Ihara Masafumi

4170824_File000000.jpg
4170824_File000000.jpg
4170824_File000001.jpg
4170824_File000001.jpg
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)